A scientific statement has been published by the American College of Cardiology regarding inflammation and cardiovascular disease.
A study presented at ACR Convergence 2025 has sparked interest among doctors and patients alike. Drugs originally made for ...
A recent systematic review identified only 47 cases of hypothyroid cardiac tamponade worldwide between 2000 and 2023, with notably no cases reported from Sub-Saharan Africa, highlighting a significant ...
An observational cohort study uses multi-omics profiling to identify distinct biomarkers that could aid in the earlier ...
Objective Interstitial lung disease (ILD) represents the most common and severe organ manifestation observed in patients ...
Ventyx Biosciences, Inc. surged after strong Phase 2 results for VTX3232 in obesity. Click for key insights and what VTYX ...
Investing.com -- Ventyx Biosciences (NASDAQ:VTYX) stock soared 45% in after-hours trading Wednesday following the company’s announcement of positive topline results from its Phase 2 study of VTX3232 ...
VTX3232 demonstrated significant reductions in cardiovascular risk factors, with additional benefits when combined with semaglutide VTX3232 ...
Most of the symptoms turn out to be benign. In some cases, excessive scar tissue can grow over the stent, the bridge mesh ...
Overall, the median duration of b/tsDMARD use was 4.3 years, longer in RA (6.3 years) than axSpA (3 years). TNF inhibitors ...
These symptoms, which are common to many conditions, can point toward persistent inflammation, the body’s alarm system that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback